vaccine, yellow fever


Sanofi Pasteur


Zuellig Pharma
Concise Prescribing Info
Yellow fever virus ≥1,000 IU (produced in specified pathogen-free chick embryos), 17D-204 strain (live, attenuated)
Active immunization against yellow fever.
Dosage/Direction for Use
IM/SC Adult & childn ≥6 mth 0.5 mL as single dose. 1st dose should be given at least 10 days before being at risk of infection w/ yellow fever. Childn w/ insufficient response to the 1st dose or after at least 10 yr Administer 0.5 mL booster dose, as needed.
Hypersensitivity to yellow fever virus vaccine, eggs or chicken proteins. Patients who have severe allergic reaction after inj of yellow fever vaccine, immunocompromised, active HIV infection; history of thymus dysfunction; illness w/ high or moderate temp or acute illness.
Special Precautions
Do not inject IV. Patients w/ HIV infection. Bleeding disorders (eg, haemophilia or low level of platelets) or concomitant use w/ drugs that reduce blood circulation. May cause fainting. False positive results of blood test for dengue or Japanese encephalitis may occur. Fructose intolerance. Pregnancy & lactation. Elderly >60 yr. Childn <9 mth.
Adverse Reactions
Headache, asthenia, pain or discomfort at the inj site, muscle pains, fever & vomiting (in childn). Fever & vomiting (in adults), painful joints, nausea, inj site reactions (eg, redness, bruising, swelling or appearance of a hard lump).
Drug Interactions
ATC Classification
J07BL - Yellow fever vaccines ; Used for active immunizations.
Stamaril powd for inj
0.5 mL x 10 × 1's;0.5 mL x 1's;0.5 mL x 20 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in